FDA Approvals of Opioids Based on Insufficient Efficacy and Safety Data

A new cross-sectional study uncovers shortcomings in pivotal trials supporting new drug applications for opioid analgesics, which range from study design to duration. Read more.

Oct. 24: National Prescription Drug Take Back Day

Published On:

AAPM Signs Letter Opposing CMS Expansion for Pre-Approval for Neurostimulator Implantation

Published On:

AAPM Signs Letter Opposing CMS Expansion for Pre-Approval for Neurostimulator Implantation

Published On:

AAPM is dedicated to advancing multidisciplinary pain care, education, advocacy, and research to improve the quality of life for our members and those they treat.

AAPM

Resources

Contact

10440 Little Patuxent Pkwy,
Ste. 300
Columbia, MD 21044

P: (800) 917-1619 Ext. 102
F: (407) 749-0714

Join Now

© American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources | Powered by Insight Marketing Group
American Academy of Pain (AAMP) is a nonprofit, 501(c)(6) tax-exempt organization.

FDA Approvals of Opioids Based on Insufficient Efficacy and Safety Data

Related Posts

Oct. 24: National Prescription Drug Take Back Day

AAPM Signs Letter Opposing CMS Expansion for Pre-Approval for Neurostimulator Implantation

AAPM Signs Letter Opposing CMS Expansion for Pre-Approval for Neurostimulator Implantation

AAPM

Resources

Contact